Treatments and Specialities

ITRT develops personalised advanced cell therapy medicines using Cultured Mesenchymal Cells (CMC), manufactured in clean rooms under GMP standards and applied with individual authorisation from the AEMPS.

Authorised clinical trials have demonstrated evidence of safety and structural regeneration in tendinopathies, osteoarthritis, discopathies, pseudoarthrosis, osteonecrosis and xerostomia. ITRT conducts clinical follow-up for up to five years to evaluate the progress and stability of the treatment.

terapida-celular-avanzada-para-la-discopatia-lumbarLumbar and cervical disc osteoarthritis. Intervertebral disc injuries
In lumbar disc degeneration, intradiscal administration of CMC has shown structural recovery on MRI and sustained pain reduction, with extended clinical follow-up.
antes-y-despues-de-una-artrosis-con-terapia-celular-avanzadaPeripheral joint osteoarthritis. Cartilage injuries
ITRT has evaluated CMC in osteoarthritis of the knee, hip, shoulder, and other peripheral joints, whether degenerative or post-traumatic, with clinical evidence of cartilage regeneration and functional improvement.
como-se-puede-curar-la-tendinopatiaTendinopathies. Tendon injuries
CMC administered intratendinously has demonstrated structural regeneration in the patellar, Achilles, hamstring, and supraspinatus tendons, validated by MRI and associated with sustained functional improvement.

Treatments and Specialities

Subscribe to our Newsletter